Skip to main content

Table 1 Characteristics of a healthy patient (#1) and four patients (#2–5) with alpha-1-antitrypsin deficiency (AATD)

From: Dark-field chest x-ray imaging: first experience in patients with alpha1-antitrypsin deficiency

Patient characteristics

#1

#2

#3

#4

#5

Gender

Male

Female

Male

Male

Male

Age (years)

33

41

48

73

55

AATD subtype

–

PiZZ

PiZZ

Pi00

PiZZ

Smoking (pack/years, stop)

Active

16, 2017

18, 2014

Never

13, 2009

Medication (year of start)

–

2018

2005

2014

2010

Duration of therapy

–

2

15

6

10

CAT-score

–

26

9

17

19

GOLD stage

–

4D

4A

2B

4B

  1. Medication and duration of therapy refer to alpha-1-antitrypsin augmentation therapy. CAT Chronic obstructive pulmonary disease assessment test, GOLD Global Initiative for Chronic Obstructive Lung Disease, PiZZ Homozygous proteinase Z-alleles, Pi00 Homozygous 0 alleles